Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;36(2):107-115.
doi: 10.1111/den.14633. Epub 2023 Aug 9.

Updates in metabolic bariatric endoscopy

Malorie Simons  1 , Reem Z Sharaiha  2
Affiliations
Review

Updates in metabolic bariatric endoscopy

Malorie Simons et al. Dig Endosc. 2024 Feb.

Abstract

Obesity and its associated comorbid conditions have been increasing globally. Endoscopic bariatric and metabolic therapies (EBMTs) were initially designed to replicate bariatric surgery physiology for those who are not or choose not to be surgical candidates. Now, newer procedures target the complicated pathophysiology underlying obesity and its comorbidities. EBMT has been categorized based on its therapeutic target (stomach or small intestine), but innovations have expanded to include extraintestinal organs including the pancreas. Gastric EBMTs, namely space-occupying balloons, gastroplasty with suturing or plication, and aspiration therapy, are primarily used for weight loss. Small bowel EBMTs are designed to cause malabsorption, epithelial endocrine remodeling, and other changes to intestinal physiology to ultimately improve the metabolic comorbidities of obesity rather than induce weight loss alone. These include duodenal mucosal resurfacing, endoluminal bypass sleeves, and incisionless anastomosis systems. Extraluminal or pancreatic EBMT is aimed to restore the production of normal pancreatic proteins that are involved in the progression of type 2 diabetes. This review discusses the current and new technologies of metabolic bariatric endoscopy, their pros and cons, and areas for future research.

Keywords: bariatric endoscopy; endoscopic metabolic therapy; weight loss.

PubMed Disclaimer

References

REFERENCES

    1. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017; 377: 13-27.
    1. Bluher M. Obesity: Global epidemiology and pathogenesis. Nat Rev Endocrinol 2019; 15: 288-98.
    1. Fryar CD, Carroll MD, Afful J. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: United States, 1960-1962 through 2017-2018 [Internet]. Hyattsville: NCHS Health E-Stats; 2020 [cited 2023 Jun 9]. Available from: https://www.cdc.gov/nchs/data/hestat/obesity-adult-17-18/obesity-adult.htm
    1. Lin X, Li H. Obesity: Epidemiology, pathophysiology, and therapeutics. Front Endocrinol (Lausanne) 2021; 12: 706978.
    1. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief 2017; 288: 1-8.